Delivery Order SPE2DB20D1100-SPE2DB24FD6R6
Award Date
9/5/24
Potential Completion Date
9/6/24
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $10,838.56 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,734,299 units of the prescription medication Vyvanse (60mg capsules) over a period ending on May 30, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, serving as the primary vehicle for the company to...
The U.S. Defense Logistics Agency (DLA) awarded a $3,274.99 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 4,565,442,423 units of the 20 mg Vyvanse capsule medication. The contract has an ultimate completion date of August 14, 2024. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous federal contracts by various defense and civilian agencies, including an Indefinite Delivery Contract (IDC)...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to supply 4,564,460,161 units of the drug Vyvanse 30 mg capsules. The firm-fixed-price contract, valued at $2,133.68, has a completion date of May 2, 2024. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 31, 2025, as well as a...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $10,833.45 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,559,778,029 units of Vyvanse 30 mg capsules. The contract has a firm fixed price and an ultimate completion date of January 31, 2023. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026, which...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division worth $1,724.00 for the supply of 4,564,712,545 units of the prescription medication Vyvanse 50mg capsules. This is a firm-fixed price contract with a completion date of May 28, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA worth up...
The Defense Logistics Agency (DLA) has awarded a $9,524.76 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of 4,565,333,941 units of the prescription drug Vyvanse 40 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of medical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, to provide 4,563,982,056 units of the drug Vyvanse 50 mg capsules. The $1,741.36 contract has a performance period through March 18, 2024 and does not utilize any set-aside designations. This delivery order is issued under a larger indefinite delivery contract (IDC) with a potential value of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of $8,920.04 worth of Vyvanse 10 mg capsules. The contract has a completion date of January 29, 2024 and was awarded on January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) with DLA to provide pharmaceutical products and medical supplies to DLA...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide 4,565,128,796 units of the prescription drug Vyvanse 20 mg capsules. The $6,573.70 firm-fixed-price contract has a completion date of July 12, 2024 and was not set aside for any specific business category. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,795.74 for the supply of 100 capsules of the drug Vyvanse 30 mg. The contract has a completion date of February 13, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) awarded by DLA...